ATE264870T1 - Verfahren zur lösung von glucagon-ähnlichen peptid-1 (glp-1) verbindungen - Google Patents

Verfahren zur lösung von glucagon-ähnlichen peptid-1 (glp-1) verbindungen

Info

Publication number: ATE264870T1
Authority: AT; Austria
Prior art keywords: glp; solution; compound; compounds; glucagon
Prior art date: 2000-01-27

Application number

AT01904785T

Other languages

English (en)

Inventor

Walter Francis Junior Prouty

Joseph Vincent Junior Rinella

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-27

Filing date

2001-01-16

Publication date

2004-05-15

2001-01-16 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2004-05-15 Application granted granted Critical

2004-05-15 Publication of ATE264870T1 publication Critical patent/ATE264870T1/de

Links

GCYXWQUSHADNBF-AAEALURTSA-N preproglucagon 78-108 Chemical class C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 GCYXWQUSHADNBF-AAEALURTSA-N 0.000 title 1
102100025101 GATA-type zinc finger protein 1 Human genes 0.000 abstract 6
101710198884 GATA-type zinc finger protein 1 Proteins 0.000 abstract 6
-1 GLP-1 compound Chemical class 0.000 abstract 4
DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 abstract 3
239000000243 solution Substances 0.000 abstract 3
239000007864 aqueous solution Substances 0.000 abstract 2
239000011260 aqueous acid Substances 0.000 abstract 1
230000006340 racemization Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Health & Medical Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Endocrinology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Analytical Chemistry (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT01904785T 2000-01-27 2001-01-16 Verfahren zur lösung von glucagon-ähnlichen peptid-1 (glp-1) verbindungen ATE264870T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US17843800P	2000-01-27	2000-01-27
US22405800P	2000-08-09	2000-08-09
PCT/US2001/000010 WO2001055213A2 (en)	2000-01-27	2001-01-16	Process for solubilizing glucagon-like peptide 1 (glp-1) compounds

Publications (1)

Publication Number	Publication Date
ATE264870T1 true ATE264870T1 (de)	2004-05-15

Family

ID=26874307

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01904785T ATE264870T1 (de)	2000-01-27	2001-01-16	Verfahren zur lösung von glucagon-ähnlichen peptid-1 (glp-1) verbindungen

Country Status (17)

Country	Link
US (4)	US7598222B2 (de)
EP (1)	EP1257577B1 (de)
JP (1)	JP2003523366A (de)
KR (1)	KR20020073184A (de)
AT (1)	ATE264870T1 (de)
AU (1)	AU2001232735A1 (de)
BR (1)	BR0107837A (de)
CA (1)	CA2396920A1 (de)
DE (1)	DE60102899T2 (de)
DK (1)	DK1257577T3 (de)
ES (1)	ES2218381T3 (de)
HU (1)	HUP0204281A3 (de)
IL (2)	IL150913A0 (de)
MX (1)	MXPA02007231A (de)
PT (1)	PT1257577E (de)
TR (1)	TR200401142T4 (de)
WO (1)	WO2001055213A2 (de)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2686899B1 (fr)	1992-01-31	1995-09-01	Rhone Poulenc Rorer Sa	Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US9006175B2 (en)	1999-06-29	2015-04-14	Mannkind Corporation	Potentiation of glucose elimination
EP2213743A1 (de)	2000-04-12	2010-08-04	Human Genome Sciences, Inc.	Albuminfusionsproteine
WO2003002136A2 (en) *	2001-06-28	2003-01-09	Novo Nordisk A/S	Stable formulation of modified glp-1
WO2005003296A2 (en)	2003-01-22	2005-01-13	Human Genome Sciences, Inc.	Albumin fusion proteins
AU2002364586A1 (en)	2001-12-21	2003-07-30	Delta Biotechnology Limited	Albumin fusion proteins
WO2003080149A2 (en)	2002-03-20	2003-10-02	Mannkind Corporation	Inhalation apparatus
CA2518465A1 (en) *	2003-03-25	2004-10-14	Takeda San Diego, Inc.	Dipeptidyl peptidase inhibitors
WO2004087910A1 (ja)	2003-03-28	2004-10-14	National Institute Of Agrobiological Sciences	組換えタンパク質が高生産された植物貯蔵器官の生産方法及び新規組換えタンパク質
JP2007511467A (ja)	2003-05-14	2007-05-10	タケダサンディエゴインコーポレイテッド	ジペプチジルペプチダーゼインヒビター
ES2375056T3 (es) *	2003-06-03	2012-02-24	Novo Nordisk A/S	Composiciones pept�?dicas farmacéuticas estabilizadas.
KR101308912B1 (ko)	2003-06-03	2013-09-23	노보 노르디스크 에이/에스	안정화된 약학적 펩티드 조성물
PL1633391T3 (pl) *	2003-06-03	2012-03-30	Novo Nordisk As	Stabilizowane farmaceutycznie kompozycje peptydowe
US8921311B2 (en)	2003-08-01	2014-12-30	Mannkind Corporation	Method for treating hyperglycemia
US9078866B2 (en)	2003-08-01	2015-07-14	Mannkind Corporation	Method for treating hyperglycemia with GLP-1
KR20060041309A (ko) *	2003-08-13	2006-05-11	다케다 야쿠힌 고교 가부시키가이샤	４-피리미돈 유도체 및 펩티딜 펩티다제 저해제로서의 그의용도
EP1699777B1 (de) *	2003-09-08	2012-12-12	Takeda Pharmaceutical Company Limited	Dipeptidylpeptidase-hemmer
EP1697342A2 (de) *	2003-09-08	2006-09-06	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitoren
DK3300721T4 (da)	2003-11-20	2025-03-03	Novo Nordisk As	Propylenglycol-holdige peptidformuleringer hvilke er optimale til fremstilling og til anvendelse i injektionsindretninger
UA85871C2 (uk) *	2004-03-15	2009-03-10	Такеда Фармасьютікал Компані Лімітед	Інгібітори дипептидилпептидази
PL1786784T3 (pl)	2004-08-20	2011-04-29	Mannkind Corp	Kataliza syntezy diketopiperazyn
KR101644250B1 (ko)	2004-08-23	2016-07-29	맨카인드 코포레이션	약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
PL1789434T3 (pl) *	2004-08-31	2014-07-31	Novo Nordisk As	Zastosowanie tris(hydroksymetylo)aminometanu do stabilizacji peptydów, polipeptydów i białek
MX2007005521A (es)	2004-11-12	2007-05-18	Novo Nordisk As	Formulaciones estables de peptidos insulinotropicos.
EP1829900B1 (de)	2004-11-19	2010-08-18	Mitsui Chemicals, Inc.	Feine partikel aus ethylenpolymer, feine partikel aus mit funktionellen gruppen modifiziertem ethylenpolymer und katalysatorträger für ihre herstellung
JP2008524331A (ja)	2004-12-21	2008-07-10	武田薬品工業株式会社	ジペプチジルペプチダーゼ阻害剤
WO2006069779A1 (en) *	2004-12-30	2006-07-06	F. Hoffmann-La Roche Ag	Preparing of peptides with excellent solubility
TW200643033A (en) *	2005-03-08	2006-12-16	Chugai Pharmaceutical Co Ltd	Conjugate of water-soluble modified hyaluronic acid and glp-1 analogue
CN101155632A (zh)	2005-04-07	2008-04-02	三井化学株式会社	含烯烃类聚合物的囊状微粒
MY147393A (en) *	2005-09-14	2012-11-30	Takeda Pharmaceutical	Administration of dipeptidyl peptidase inhibitors
PT1931350E (pt) *	2005-09-14	2014-02-12	Takeda Pharmaceutical	Administração de inibidores de dipeptidil peptidase
CN104324362B (zh)	2005-09-14	2018-04-24	曼金德公司	以提高活性试剂对结晶微粒表面的亲和力为基础的药物配制方法
PE20070622A1 (es) *	2005-09-14	2007-08-22	Takeda Pharmaceutical	Administracion de inhibidores de dipeptidil peptidasa
TW200745079A (en) *	2005-09-16	2007-12-16	Takeda Pharmaceuticals Co	Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
CA2622642C (en) *	2005-09-16	2013-12-31	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors
TW200745080A (en) *	2005-09-16	2007-12-16	Takeda Pharmaceuticals Co	Polymorphs of tartrate salt of 2-[2-(3-(R)-amino-piperidin-1-yl)-5-fluoro-6-oxo-6H-pyrimidin-1-ylmethyl]-benzonitrile and methods of use therefor
BRPI0707599A2 (pt)	2006-02-08	2011-05-10	Lonza Ag	sÍntese de peptÍdeo semelhante a glucagon
IN2015DN00888A (de)	2006-02-22	2015-07-10	Mannkind Corp
WO2007112368A1 (en) *	2006-03-28	2007-10-04	Takeda Pharmaceutical Company Limited	Preparation of (r)-3-aminopiperidine dihydrochloride
WO2007112347A1 (en)	2006-03-28	2007-10-04	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors
MX2009002772A (es) *	2006-09-13	2009-05-28	Takeda Pharmaceutical	Uso de 2-6-(3-amino-piperidin-1-il)-3-metil-2,4-dioxo-3,4-dihidro- 2h-pirimidin-1-ilmetil-4-fluoro-benzonitrilo.
US8324383B2 (en)	2006-09-13	2012-12-04	Takeda Pharmaceutical Company Limited	Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) *	2006-11-29	2008-10-01	Takeda Pharmaceutical	Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en)	2007-03-13	2012-01-10	Takeda Pharmaceuticals Company Limited	Weekly administration of dipeptidyl peptidase inhibitors
US8485180B2 (en)	2008-06-13	2013-07-16	Mannkind Corporation	Dry powder drug delivery system
ES2929343T3 (es)	2008-06-13	2022-11-28	Mannkind Corp	Inhalador de polvo seco accionado por aspiración para la administración de fármacos
KR101628410B1 (ko)	2008-06-20	2016-06-08	맨카인드 코포레이션	흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
TWI614024B (zh)	2008-08-11	2018-02-11	曼凱公司	超快起作用胰島素之用途
US8314106B2 (en)	2008-12-29	2012-11-20	Mannkind Corporation	Substituted diketopiperazine analogs for use as drug delivery agents
DK2405963T3 (da)	2009-03-11	2013-12-16	Mannkind Corp	Apparat, system og fremgangsmåde til at måle modstand i en inhalator
CN104721825B (zh)	2009-06-12	2019-04-12	曼金德公司	具有确定比表面积的二酮哌嗪颗粒
US8642548B2 (en) *	2009-08-07	2014-02-04	Mannkind Corporation	Val (8) GLP-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome
WO2011056889A1 (en)	2009-11-03	2011-05-12	Mannkind Corporation	An apparatus and method for simulating inhalation efforts
IL223742A (en)	2010-06-21	2016-06-30	Mannkind Corp	A dry powder inhaler and preparation for it
CN102718858B (zh) *	2011-03-29	2014-07-02	天津药物研究院	胰高血糖素样肽-1类似物单体、二聚体及其制备方法与应用
AU2012236150B2 (en)	2011-04-01	2016-03-31	Mannkind Corporation	Blister package for pharmaceutical cartridges
WO2012174472A1 (en)	2011-06-17	2012-12-20	Mannkind Corporation	High capacity diketopiperazine microparticles
BR112014009686A2 (pt)	2011-10-24	2018-08-07	Mannkind Corp	composição analgésica inalável, pó seco e método para tratar dor
CN104619369B (zh)	2012-07-12	2018-01-30	曼金德公司	干粉药物输送系统和方法
US10159644B2 (en)	2012-10-26	2018-12-25	Mannkind Corporation	Inhalable vaccine compositions and methods
AU2014228415B2 (en)	2013-03-15	2018-08-09	Mannkind Corporation	Microcrystalline diketopiperazine compositions and methods
US10450343B2 (en)	2013-03-21	2019-10-22	Sanofi-Aventis Deutschland Gmbh	Synthesis of cyclic imide containing peptide products
CA2907454C (en)	2013-03-21	2021-05-04	Sanofi-Aventis Deutschland Gmbh	Synthesis of hydantoin containing peptide products
MX375448B (es)	2013-07-18	2025-03-06	Mannkind Corp	Composiciones farmacéuticas en polvo seco estables al calor y métodos.
US11446127B2 (en)	2013-08-05	2022-09-20	Mannkind Corporation	Insufflation apparatus and methods
US10307464B2 (en)	2014-03-28	2019-06-04	Mannkind Corporation	Use of ultrarapid acting insulin
US10561806B2 (en)	2014-10-02	2020-02-18	Mannkind Corporation	Mouthpiece cover for an inhaler
US10308677B2 (en)	2014-12-19	2019-06-04	Cem Corporation	Coupling method for peptide synthesis at elevated temperatures
US9969769B2 (en)	2014-12-19	2018-05-15	Cem Corporation	Coupling method for peptide synthesis at elevated temperatures
UA127495C2 (uk)	2015-12-23	2023-09-13	Амджен Інк.	Виділений антигензв'язуючий білок, який специфічно зв'язується з поліпептидом рецептора шлункового інгібіторного пептиду (gipr) людини, та фармацевтична композиція, яка його містить
IL313587A (en)	2017-01-17	2024-08-01	Amgen Inc	Method of treating or ameliorating metabolic disorders using glp-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (gipr)
EA201992502A1 (ru)	2017-06-20	2020-04-22	Эмджен Инк.	Способ лечения или уменьшения интенсивности метаболических нарушений с применением белков, связывающих рецептор гастроингибиторного пептида (gipr), в комбинации с агонистами glp-1
EP3642238A1 (de)	2017-06-21	2020-04-29	Amgen Inc.	Verfahren zur behandlung oder linderung von stoffwechselstörungen unter verwendung von antagonistischen bindungsproteinen für rezeptoragonistfusionsproteine des gastrischen inhibitorpeptidrezeptors (gipr)/glp-1
KR102665710B1 (ko)	2017-08-24	2024-05-14	노보 노르디스크 에이/에스	Glp-1 조성물 및 그 용도
EP3728303A1 (de)	2017-12-19	2020-10-28	Novo Nordisk A/S	Löslichkeit von glp-1-peptid
WO2019200594A1 (zh) *	2018-04-19	2019-10-24	杭州先为达生物科技有限公司	酰化的glp-1衍生物
JP7761567B2 (ja)	2020-02-18	2025-10-28	ノヴォノルディスクアー／エス	医薬製剤
EP4281039A2 (de)	2021-01-25	2023-11-29	Mylan Ireland Limited	Pharmazeutische glp-peptid-zusammensetzungen und verfahren zu ihrer herstellung
WO2022266927A1 (zh) *	2021-06-24	2022-12-29	深圳翰宇药业股份有限公司	一种利拉鲁肽变构体及其制备方法、应用
WO2024166998A1 (ja)	2023-02-09	2024-08-15	三井化学株式会社	マグネシウム化合物粒子の製造方法、オレフィン重合体粒子形状の制御方法、オレフィン重合体粒子

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3419824A1 (de) *	1984-05-26	1985-11-28	Bayer Ag, 5090 Leverkusen	Verfahren und formwerkzeug zum herstellen von formteilen mit grill-, gitter- oder rostartigen bereichen, wie kfz-soft-faces, spoiler, bumper, aus einer fliessfaehigen masse
HU225496B1 (en) *	1993-04-07	2007-01-29	Scios Inc	Pharmaceutical compositions of prolonged delivery, containing peptides
US6384016B1 (en) *	1998-03-13	2002-05-07	Novo Nordisk A/S	Stabilized aqueous peptide solutions
US6380357B2 (en)	1997-12-16	2002-04-30	Eli Lilly And Company	Glucagon-like peptide-1 crystals
US6844321B2 (en) *	2000-01-31	2005-01-18	Novo Nordisk A/S	Crystallization of a GLP-1 analogue

2001
- 2001-01-16 MX MXPA02007231A patent/MXPA02007231A/es active IP Right Grant
- 2001-01-16 ES ES01904785T patent/ES2218381T3/es not_active Expired - Lifetime
- 2001-01-16 KR KR1020027009546A patent/KR20020073184A/ko not_active Ceased
- 2001-01-16 HU HU0204281A patent/HUP0204281A3/hu not_active Application Discontinuation
- 2001-01-16 AT AT01904785T patent/ATE264870T1/de not_active IP Right Cessation
- 2001-01-16 EP EP01904785A patent/EP1257577B1/de not_active Expired - Lifetime
- 2001-01-16 AU AU2001232735A patent/AU2001232735A1/en not_active Abandoned
- 2001-01-16 DE DE60102899T patent/DE60102899T2/de not_active Expired - Lifetime
- 2001-01-16 WO PCT/US2001/000010 patent/WO2001055213A2/en not_active Ceased
- 2001-01-16 DK DK01904785T patent/DK1257577T3/da active
- 2001-01-16 US US10/169,657 patent/US7598222B2/en not_active Expired - Fee Related
- 2001-01-16 BR BR0107837-2A patent/BR0107837A/pt not_active IP Right Cessation
- 2001-01-16 JP JP2001561060A patent/JP2003523366A/ja not_active Withdrawn
- 2001-01-16 PT PT01904785T patent/PT1257577E/pt unknown
- 2001-01-16 IL IL15091301A patent/IL150913A0/xx unknown
- 2001-01-16 CA CA002396920A patent/CA2396920A1/en not_active Abandoned
- 2001-01-16 TR TR2004/01142T patent/TR200401142T4/xx unknown
2008
- 2008-02-07 IL IL189371A patent/IL189371A0/en unknown
2009
- 2009-09-01 US US12/551,841 patent/US8222205B2/en not_active Expired - Fee Related
2012
- 2012-04-27 US US13/458,057 patent/US8268780B2/en not_active Expired - Fee Related
- 2012-08-10 US US13/571,443 patent/US8455433B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
TR200401142T4 (tr)	2004-07-21
US8455433B2 (en)	2013-06-04
KR20020073184A (ko)	2002-09-19
BR0107837A (pt)	2003-01-14
MXPA02007231A (es)	2002-12-09
US7598222B2 (en)	2009-10-06
IL150913A0 (en)	2003-02-12
HUP0204281A3 (en)	2007-03-28
DK1257577T3 (da)	2004-08-02
US8268780B2 (en)	2012-09-18
DE60102899T2 (de)	2005-03-31
ES2218381T3 (es)	2004-11-16
JP2003523366A (ja)	2003-08-05
US20120208980A1 (en)	2012-08-16
US20130072658A1 (en)	2013-03-21
WO2001055213A3 (en)	2002-02-28
PT1257577E (pt)	2004-08-31
US20110053838A1 (en)	2011-03-03
EP1257577B1 (de)	2004-04-21
US8222205B2 (en)	2012-07-17
US20120101034A9 (en)	2012-04-26
WO2001055213A2 (en)	2001-08-02
HUP0204281A2 (hu)	2003-04-28
DE60102899D1 (de)	2004-05-27
CA2396920A1 (en)	2001-08-02
EP1257577A2 (de)	2002-11-20
AU2001232735A1 (en)	2001-08-07
US20030060412A1 (en)	2003-03-27
IL189371A0 (en)	2008-06-05

Legal Events

Date

Code

Title

Description

2004-12-15

UEP

Publication of translation of european patent specification

Ref document number: 1257577

Country of ref document: EP

2007-10-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE264870T1 (de)	2004-05-15	Verfahren zur lösung von glucagon-ähnlichen peptid-1 (glp-1) verbindungen
ATE52282T1 (de)	1990-05-15	Saure, pseudoplastische zusammensetzungen.
ATE526401T1 (de)	2011-10-15	Verfahren zur herstellung von proteinen mit freien cysteinresten
ATE246702T1 (de)	2003-08-15	Verfahren zur darstellung von oligonukleotiden
MY149528A (en)	2013-09-13	A method of treating an aqueous system containing or in contact with metal sulphide scale
BR0212652A (pt)	2004-08-24	Composição para o tratamento de uma formação subterrânea, método de tratamento de uma formação subterrânea para aumentar a permeabilidade, e método de tratamento de um conjunto de escoramento numa fratura numa formação subterrânea para aumentar a sua permeabilidade
NZ515561A (en)	2003-06-30	Method for the production of thiazolidin
ATE342231T1 (de)	2006-11-15	Verfahren zur abreicherung der metallionenkonzentration in salzlösungen
DK390689D0 (da)	1989-08-09	Fremgangsmaade til fremstilling af des-b30-insuliner og des-b30-insulinderivater
EP0296581A3 (de)	1990-06-20	Aminosäure-1,2-Diketo-Derivate als Renin-Hemmungsstoffe
ATE352547T1 (de)	2007-02-15	Verfahren zur herstellung von eisenhydroxypyronverbindungen
DE60123125D1 (de)	2006-10-26	Verfahren zur herstellung von 1-(aminomethyl) cyclohexanessigsäure
DE60105016D1 (de)	2004-09-23	Verfahren zur reinigung eines salzes der clavulansäure
DE60017504D1 (de)	2005-02-24	Verfahren zur Gewinnung von Perfluorsäuren aus wässriger Lösung
DE69813794D1 (de)	2003-05-28	Reinigung von polyphosphazensäure
DE69926642D1 (de)	2005-09-15	Verfahren zur herstellung von n-geschützten azetidin-2-carbonsäuren
ATE222887T1 (de)	2002-09-15	Verfahren zur herstellung von inorganischen salzen von optisch aktiven phenylglycin-derivaten
ATE356091T1 (de)	2007-03-15	Stabilisierte wässrige folsäurezubereitung und verfahren zu dessen herstellung
ATE130844T1 (de)	1995-12-15	Verfahren zur extraktion eines aminosäureesters.
DE60130385D1 (de)	2007-10-25	Verfahren zur Erhöhung der Eierproduktion und Verfestigung von Eierschalen bei Geflügel
DE50015648D1 (de)	2009-07-02	Verfahren zur herstellung von 4-amino-5-chlor-1-phenylpyridazinon
DE60228448D1 (de)	2008-10-02	Verfahren zur herstellung von aminostilbenderivaten
RU93030943A (ru)	1996-04-27	Способ получения кислотно-аддитивных солей труднорастворимых карбоновых кислот и аминов или аминокислот
DK67394A (da)	1995-12-14	Fremgangsmåde til genvinding af stærke syrer fra vandige opløsninger
WO2002062355A3 (en)	2003-02-06	Hydriodic acid and iodide salts for treatment of male impotence